These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27608708)

  • 1. Hypersensitivity Reactions in HIV Infected Individuals after Substitution of Antiretroviral Drug Regimen: Need for Pharmacovigilance in the National Program.
    Ghate MV; Kadam DB; Gurav NP; Rewari BB; Gangakhedkar RR
    J Assoc Physicians India; 2015 Oct; 63(10):94-5. PubMed ID: 27608708
    [No Abstract]   [Full Text] [Related]  

  • 2. A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
    de Perio MA; Gomez FJ; Frame PT; Fichtenbaum CJ
    AIDS; 2007 Oct; 21(16):2252-3. PubMed ID: 18090057
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical presentations of severe cutaneous drug reactions in HIV-infected Africans.
    Lehloenya RJ; Kgokolo M
    Dermatol Clin; 2014 Apr; 32(2):227-35. PubMed ID: 24680008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Yes, simplify antiretroviral treatments, but not at a significant price!].
    Casalino E
    Med Mal Infect; 2005 Apr; 35 Suppl 1():S11-4. PubMed ID: 15922875
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiretroviral drugs in HIV-infected children.
    Viganò A; Manfredini V; Penagini F; Giacomet V; Zuccotti GV
    Pharmacol Res; 2011 Jul; 64(1):1-3. PubMed ID: 21255650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy: a primer for dermatologists.
    Kim HN; Harrington RD
    Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort Analysis.
    Sun J; Liu L; Shen J; Qi T; Wang Z; Song W; Zhang R; Lu H
    PLoS One; 2015; 10(7):e0133242. PubMed ID: 26207639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inappropriate combinations of antiretroviral drugs].
    Machala L; Cerný R
    Klin Mikrobiol Infekc Lek; 2004 Oct; 10(5):241-3. PubMed ID: 15558454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [When to start antiretroviral therapy].
    Elzi L; Battegay M
    Ther Umsch; 2014 Jan; 71(1):23-9. PubMed ID: 24394206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era.
    Baker JV; Henry K
    Ann Intern Med; 2011 Apr; 154(8):563-5. PubMed ID: 21502654
    [No Abstract]   [Full Text] [Related]  

  • 11. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014.
    Awodele O; Ibrahim A; Orhii P
    Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential adverse effects and inferior efficacy in ARV treatment.
    Graves D; Cocohoba J; Gruta C; Goldschmidt R
    J Natl Med Assoc; 2004 May; 96(5):692-3; author reply 693. PubMed ID: 15160990
    [No Abstract]   [Full Text] [Related]  

  • 14. Efavirenz severe hypersensitivity reaction: case report and rapid desensitization protocol development.
    Khalili H; Farasatinasab M; Hajiabdolbaghi M
    Ann Pharmacother; 2012 May; 46(5):e12. PubMed ID: 22535841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.
    Martin AM; Nolan D; Gaudieri S; Phillips E; Mallal S
    Pharmacogenomics; 2004 Sep; 5(6):643-55. PubMed ID: 15335286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What does the generalist need to know about HIV infection?
    Gallant JE
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):5-18. PubMed ID: 20005484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment antiretroviral exposure from recreational use.
    Grelotti DJ; Closson EF; Mimiaga MJ
    Lancet Infect Dis; 2013 Jan; 13(1):10-2. PubMed ID: 23257221
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV is associated with thrombophilia and high D-dimer in children and adolescents.
    Pontrelli G; Martino AM; Tchidjou HK; Citton R; Mora N; Ravà L; Tozzi AE; Palma P; Muraca M; Franco E; Rossi P; Bernardi S
    AIDS; 2010 May; 24(8):1145-51. PubMed ID: 20168205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy and tuberculosis: does the regimen matter?
    van Leth F; Wit FW; Hermans SM
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):5-7. PubMed ID: 24256498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of antiretroviral agents: is the list getting longer?
    Fine DM; Gallant JE
    J Infect Dis; 2013 May; 207(9):1349-51. PubMed ID: 23382574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.